DAVID WILLIAMS: Open Payments
NPI 1710022017 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,996 in 98 payments from 21 companies in 2025. Trend: 2023 $3,214 · 2024 $2,975 · 2025 $2,996
Food & beverage: $2,921Education: $75
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $718 |
| Novo Nordisk Inc | 15 | $485 |
| ABBVIE INC. | 10 | $282 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $170 |
| Regeneron Healthcare Solutions, Inc. | 3 | $169 |
| Braeburn Inc. | 4 | $145 |
| GENZYME CORPORATION | 2 | $142 |
| Lilly USA, LLC | 8 | $130 |
| Abbott Laboratories | 1 | $129 |
| GlaxoSmithKline, LLC. | 7 | $118 |
Products named: AIRSUPRA, DUPIXENT, Ozempic, BREZTRI, UBRELVY, Kerendia, BRIXADI, REXULTI.
Industry payments across MI — which companies pay providers there.
